These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14559799)

  • 1. Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer.
    Yu J; Marsh S; Ahluwalia R; McLeod HL
    Cancer Res; 2003 Oct; 63(19):6170-3. PubMed ID: 14559799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin.
    Ichikawa W; Ooyama A; Toda E; Sugimoto Y; Oka T; Takahashi T; Shimizu M; Sasaki Y; Hirayama R
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):794-801. PubMed ID: 16528528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.
    Spindler KL; Nielsen JN; Ornskov D; Brandslund I; Jakobsen A
    Acta Oncol; 2007; 46(8):1113-7. PubMed ID: 17851837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer.
    Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ; Zhu ZZ; Cong WM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal cancer.
    Yoshiya G; Takahata T; Hanada N; Suzuki K; Ishiguro A; Saito M; Sasaki M; Fukuda S
    J Gastroenterol Hepatol; 2008 Jun; 23(6):948-53. PubMed ID: 18205772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
    Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
    Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
    Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
    Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients.
    Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J
    World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers.
    Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
    Eur J Cancer; 2005 Sep; 41(14):2176-83. PubMed ID: 16182121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
    J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coding region polymorphisms in the CHFR mitotic stress checkpoint gene are associated with colorectal cancer risk.
    Kang HC; Kim IJ; Jang SG; Hong SH; Hwang JA; Shin HR; Park JG
    Cancer Lett; 2008 Feb; 260(1-2):170-9. PubMed ID: 18079053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer.
    Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J
    Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.